Researchers at Bellvitge Biomedical Research Institute will develop a research project with the company Pharmacelera to look for new molecules that block the cohesin complex, with applications in several difficult-to-treat cancers, such as myeloid leukemia, glioblastomas, Ewing sarcomas, colon cancer and bladder cancer
More than 300 people attended the festival of research & innovation on health, held at IDIBELL.
The first Edition of Sinergia opened doors to research and innovation of L’Hospitalet Read More »
Saturday, November 16, from 10 a.m. to 2 p.m., open day at the facilities of the Duran i Reynals Hospital. This event wants to showcase the responsible and innovative research carried out at the Bellvitge Biomedical Pole
Here comes Sinergia, the festival of research and innovation in health of L’Hospitalet Read More »
The conference on health innovation Innovation for value, held on November 8 in Barcelona, has analyzed the opportunities offered by technological advances in the field of health. The conference, organized by the Bellvitge Biomedical Research Institute (IDIBELL) and the Platform for Innovation in Medical and Health Technologies (ITEMAS), has been attended by some of the
Innovation for value analyzes the use of big data and the new power it gives to patients Read More »
On the occasion of the Spanish Congress of Cardiology, a meeting of the researchers participating in the project has taken place. The project is part of a territorial program that integrates hospital and primary care
Bellvitge begins telemedicine monitoring of patients with chronic heart failure Read More »
The “U.S. Federal sources for health Projects” informative session was successfully held at IDIBELL last October 21st. Jointly co-organized with AGAUR, the Agency for Management of University and Research Grants, the session featured two seminars on U.S. funding sources for Health Projects, that were delivered by Dr. Ana Turchetti-Maia, Director of Business Development at Freemind
Successful informative session on U.S. Non-dilutive funding at IDIBELL Read More »
The finding has a clear clinical relevance, since it will facilitate patient selection to offer a more specific therapy
Scientists discover the implication of a new protein involved in liver cancer Read More »
The consul general of France in Barcelona, Cyril Piquemal, visited IDIBELL on October 23rd in order to get to know the institute and promote collaborations and synergies with French institutions. The visit took place as part of the efforts made by the French consulate to strengthen the interaction between research centers in Catalonia and France.
The consul general of France in Barcelona visits IDIBELL Read More »
At first glance, a one-millimeter worm that needs to be observed with a magnifying glass does not resemble a human being at all. However, the nematode Caenorhabditis elegans, an animal model widely used in biomedical research by hundreds of laboratories around the world, has approximately the same number of genes that humans have, about 20,000.
The event, co-organized by the Bellvitge Biomedical Research Institute (IDIBELL) and the Platform for Innovation in Medical and Health Technologies (ITEMAS), will take place on November 8 at the Bellvitge University Hospital
Innovation for value turns Barcelona into the world capital of health innovation Read More »
